A study to compare post-operative inflammation between subconjunctival triamcinolone acetate versus prednisolone drops group after cataract surgery
- Conditions
- Health Condition 1: H25- Age-related cataract
- Registration Number
- CTRI/2023/02/049635
- Lead Sponsor
- GGSMCH Faridkot
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients with age related cataract who can be taken up for uncomplicated phacoemulsification surgery (Nuclear opalescence grade 2-5 , cortical grade 2-5, posterior subcapsular grade 2-5 according LOCS III classification
1Known allergy to any of the contents of the pharmaceuticals used in the study
2Posterior polar cataract
3Uveitis
4Glaucoma
5Cystoid macular edema ( clinically significant )
6Retinal abnormality causing cystoid macular edema eg diabetes, vein occlusion, subretinal neovascular membrane.
7Exclusion after enrollment: significant complications to surgery such as posterior capsule rupture, vitreous loss and dislocated lens or cortical material. These surgical complications may cause excessive inflammation and these patients would be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Control of inflammation measured by: <br/ ><br>1. Anterior chamber inflammation <br/ ><br>2. central sub foveal thickness - OCTTimepoint: 6 weeks for each patient; 1.5-2 year for whole study
- Secondary Outcome Measures
Name Time Method To record the post operative adverse effects including intraocular pressure (IOP), <br/ ><br>subconjunctival hemorrhage of subconjunctival triamcinolone acetate in comparison to topical steroid <br/ ><br>eye dropsTimepoint: 6 weeks for each patient; 1.5-2 year for whole study